시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 방사선 치료에 의한 구강 점막염 치료 시장 보고서(2025년)
Radiotherapy Induced Oral Mucositis Treatment Global Market Report 2025
상품코드 : 1720876
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,319,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,134,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,949,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

방사선 치료에 의한 구강 점막염 치료 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 유병률 상승, 원격 의료 서비스의 확대, 재택 케어 솔루션 수요 증가가 원동력이 될 것으로 예측됩니다. 이 기간의 주요 동향에는 강도조절 방사선 치료 기술의 진보, 표적 요법의 개발, 원격 의료의 통합, 맞춤형 의료 접근, 화상 진단 기술의 향상 등이 있습니다.

세계의 암 유병률의 상승은 방사선 치료에 의한 구강 점막염 치료 시장의 성장을 가속할 것으로 예측됩니다. 전자 돌연변이에서 발생합니다. 암 세계의 유병률 증가는 인구의 고령화, 담배의 사용, 비만, 음주 등의 라이프 스타일의 선택, 대기 오염 등의 환경의 영향 등의 요인에 의한 점이 큽니다. 통증을 동반하는 부작용에 대처하는 것을 돕고, 치료에 대한 내약성을 높이고, 적절한 영양 섭취를 유지할 수 있도록 하고, 최종적으로는 암 치료 중의 삶의 질을 향상시킵니다. 2024년 8월 영국 기반의 자선 단체인 맥밀란 암 지원(Macmillan Cancer Support)은 2024년에 영국에서 300만 명 이상이 암을 안고 살아가고 있으며, 이 수는 2025년까지 350만명, 2030년까지 400만명, 2040년까지 530만명으로 증가할 것으로 예측했습니다. 따라서, 세계의 암 유병률의 상승이 방사선 치료에 의한 구강 점막염 치료 시장의 성장을 견인하고 있습니다.

방사선 치료에 의한 구강 점막염 치료 시장의 주요 기업은 저레벨 레이저 치료 등 혁신적인 제품의 개척에 주력하고 있으며, 암 치료 중 치유 촉진, 통증 경감, 환자 결과 개선을 도모하고 있습니다. 레이저 치료는 콜드 레이저 치료 및 포토 바이오 모듈레이션으로도 알려져 있으며 저출력 레이저 및 LED를 사용하여 치유를 촉진하고 통증과 염증을 억제하는 비 침습적 치료법입니다. 예를 들어 2024년 10월 미국 제약회사 재규어 헬스는 구강 점막염 처방 젤인 젤 클레어를 발매했습니다. 구강 점막염과 관련된 통증을 관리하기 위해 특별히 고안된 Gelclair는 구강 점막 표면에 부착하고 다른 치료에 일반적으로 수반되는 치크 틱과 감각을 동반하지 않고 신속하고 장기적인 통증 완화를 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별, 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Radiotherapy-induced oral mucositis treatment involves medical interventions aimed at managing and alleviating the painful condition of oral mucositis caused by radiotherapy. These treatments focus on reducing inflammation, preventing infection, relieving pain, and promoting healing of the mucosal tissues in the mouth, which are damaged during cancer treatments, especially in patients receiving radiotherapy for head and neck cancers.

The primary drug classes used in treating radiotherapy-induced oral mucositis include antibiotics, antifungals, anti-inflammatory agents, and anti-neoplastic drugs. Antibiotics help prevent or treat bacterial infections by either killing the bacteria or inhibiting their growth. Treatment options include topical agents, systemic medications, and medical devices. Radiotherapy techniques used in treatment include external beam radiation therapy (EBRT), intensity-modulated radiation therapy (IMRT), brachytherapy, proton therapy, stereotactic radiosurgery (SRS), and others. The severity of oral mucositis is categorized as mild, moderate, or severe. This treatment is typically administered in hospitals, oncology centers, research institutes, and dental clinics.

The radiotherapy induced oral mucositis treatment market research report is one of a series of new reports from The Business Research Company that provides radiotherapy induced oral mucositis treatment market statistics, including the radiotherapy induced oral mucositis treatment industry's global market size, regional shares, competitors with a radiotherapy induced oral mucositis treatment market share, detailed radiotherapy induced oral mucositis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the radiotherapy induced oral mucositis treatment industry. This radiotherapy induced oral mucositis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The radiotherapy induced oral mucositis treatment market size has grown strongly in recent years. It will grow from $1.76 billion in 2024 to $1.85 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth during the historic period can be attributed to the rising global incidence of cancer, increased awareness of oral mucositis, a higher prevalence of head and neck cancers, the expansion of healthcare infrastructure, and a growing demand for supportive care solutions.

The radiotherapy induced oral mucositis treatment market size is expected to see strong growth in the next few years. It will grow to $2.27 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period is expected to be driven by the increasing adoption of regenerative medicine approaches, the rising incidence of radiotherapy, a higher prevalence of chronic diseases, the expansion of telehealth services, and a growing demand for home-based care solutions. Key trends during this period include advancements in intensity-modulated radiotherapy techniques, the development of targeted therapies, integration of telemedicine, personalized medicine approaches, and improvements in imaging techniques.

The rising global prevalence of cancer is expected to drive the growth of the radiotherapy-induced oral mucositis treatment market. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells, which can invade surrounding tissues and organs. This condition arises from genetic mutations influenced by environmental and lifestyle factors. The increasing global prevalence of cancer is largely attributed to factors such as an aging population, lifestyle choices such as tobacco use, obesity, and alcohol consumption, as well as environmental influences such as air pollution. Radiotherapy-induced oral mucositis treatment helps cancer patients manage the painful side effects of mucosal damage caused by radiotherapy, allowing them to better tolerate treatment and maintain proper nutritional intake, which ultimately improves their quality of life during cancer care. For example, in August 2024, Macmillan Cancer Support, a UK-based charitable organization, reported that more than 3 million people in the UK were living with cancer in 2024, and this number is projected to increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the rising global prevalence of cancer is driving the growth of the radiotherapy-induced oral mucositis treatment market.

Leading companies in the radiotherapy-induced oral mucositis treatment market are focusing on developing innovative products, such as low-level laser therapy, to accelerate healing, reduce pain, and improve patient outcomes during cancer treatment. Low-level laser therapy, also known as cold laser therapy or photobiomodulation, is a non-invasive treatment that uses low-power lasers or light-emitting diodes (LEDs) to stimulate healing and reduce pain and inflammation. For example, in October 2024, Jaguar Health Inc., a US-based pharmaceutical company, launched Gelclair, an oral mucositis prescription gel. Specifically designed to manage the pain associated with oral mucositis, a condition that affects up to 90% of head and neck cancer patients undergoing chemotherapy and radiotherapy, Gelclair adheres to the mucosal surface of the mouth, providing rapid and long-lasting pain relief without the stinging or numbing effects typically associated with other treatments.

In September 2024, InfuSystem Holdings Inc., a US-based healthcare services company, partnered with ChemoMouthpiece LLC. This partnership enables InfuSystem to exclusively distribute the Chemo Mouthpiece in the United States, aiming to reduce the incidence and severity of oral mucositis in cancer patients undergoing chemotherapy and radiotherapy. ChemoMouthpiece LLC is a US-based company offering a treatment for radiotherapy-induced oral mucositis.

Major players in the radiotherapy induced oral mucositis treatment market are Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Zydus Cadila Health Care Limited, Leo Pharma A/S, Glenmark Pharmaceuticals Ltd., Almirall S.A., Fagron Group BV, Sage Products LLC, Soligenix Inc., EUSA Pharma Ltd., Galera Therapeutics Inc., Enzychem Lifesciences Corp., Jaguar Health Inc., EpicentRx Inc., MONOPAR Therapeutics Inc., Solasia Pharma KK, Cellceutix Corporation, Innovation Pharmaceuticals Inc.

North America was the largest region in the radiotherapy induced oral mucositis treatment market in 2024. The regions covered in radiotherapy induced oral mucositis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the radiotherapy induced oral mucositis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radiotherapy-induced oral mucositis treatment market includes revenues earned by entities by providing services such as symptom management, cryotherapy, wound care and healing support, and pharmacological interventions and related products, including mouthwashes and rinses, topical gels and creams, oral sprays, and hydrogels and hydrating agents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiotherapy Induced Oral Mucositis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiotherapy induced oral mucositis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for radiotherapy induced oral mucositis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The radiotherapy induced oral mucositis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Radiotherapy Induced Oral Mucositis Treatment Market Characteristics

3. Radiotherapy Induced Oral Mucositis Treatment Market Trends And Strategies

4. Radiotherapy Induced Oral Mucositis Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Radiotherapy Induced Oral Mucositis Treatment Growth Analysis And Strategic Analysis Framework

6. Radiotherapy Induced Oral Mucositis Treatment Market Segmentation

7. Radiotherapy Induced Oral Mucositis Treatment Market Regional And Country Analysis

8. Asia-Pacific Radiotherapy Induced Oral Mucositis Treatment Market

9. China Radiotherapy Induced Oral Mucositis Treatment Market

10. India Radiotherapy Induced Oral Mucositis Treatment Market

11. Japan Radiotherapy Induced Oral Mucositis Treatment Market

12. Australia Radiotherapy Induced Oral Mucositis Treatment Market

13. Indonesia Radiotherapy Induced Oral Mucositis Treatment Market

14. South Korea Radiotherapy Induced Oral Mucositis Treatment Market

15. Western Europe Radiotherapy Induced Oral Mucositis Treatment Market

16. UK Radiotherapy Induced Oral Mucositis Treatment Market

17. Germany Radiotherapy Induced Oral Mucositis Treatment Market

18. France Radiotherapy Induced Oral Mucositis Treatment Market

19. Italy Radiotherapy Induced Oral Mucositis Treatment Market

20. Spain Radiotherapy Induced Oral Mucositis Treatment Market

21. Eastern Europe Radiotherapy Induced Oral Mucositis Treatment Market

22. Russia Radiotherapy Induced Oral Mucositis Treatment Market

23. North America Radiotherapy Induced Oral Mucositis Treatment Market

24. USA Radiotherapy Induced Oral Mucositis Treatment Market

25. Canada Radiotherapy Induced Oral Mucositis Treatment Market

26. South America Radiotherapy Induced Oral Mucositis Treatment Market

27. Brazil Radiotherapy Induced Oral Mucositis Treatment Market

28. Middle East Radiotherapy Induced Oral Mucositis Treatment Market

29. Africa Radiotherapy Induced Oral Mucositis Treatment Market

30. Radiotherapy Induced Oral Mucositis Treatment Market Competitive Landscape And Company Profiles

31. Radiotherapy Induced Oral Mucositis Treatment Market Other Major And Innovative Companies

32. Global Radiotherapy Induced Oral Mucositis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Radiotherapy Induced Oral Mucositis Treatment Market

34. Recent Developments In The Radiotherapy Induced Oral Mucositis Treatment Market

35. Radiotherapy Induced Oral Mucositis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기